Opaleye Management Inc. acquired a new position in shares of Aadi Bioscience, Inc. (NASDAQ:AADI – Get Rating) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 252,046 shares of the company’s stock, valued at approximately $3,234,000. Aadi Bioscience accounts for approximately […]
Aadi Bioscience (NASDAQ:AADI – Get Rating) had its price target lowered by LADENBURG THALM/SH SH from $47.00 to $33.00 in a research report sent to investors on Thursday morning, The Fly reports. Separately, HC Wainwright reduced their price objective on shares of Aadi Bioscience from $48.00 to $45.00 and set a buy rating for the […]
Aadi Bioscience, Inc. (NASDAQ:AADI – Get Rating) Chairman Neil Desai sold 7,695 shares of the firm’s stock in a transaction on Wednesday, May 3rd. The shares were sold at an average price of $7.68, for a total value of $59,097.60. Following the completion of the transaction, the chairman now owns 1,833,848 shares of the company’s […]
Aadi Bioscience (NASDAQ:AADI – Get Rating) is scheduled to be issuing its quarterly earnings data before the market opens on Wednesday, May 10th. Analysts expect the company to announce earnings of ($0.58) per share for the quarter. Aadi Bioscience Stock Performance AADI traded down $0.11 during trading on Thursday, hitting $7.62. The stock had a […]
Aadi Bioscience (NASDAQ:AADI – Get Rating) and Arvinas (NASDAQ:ARVN – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, dividends, profitability, risk, institutional ownership and earnings. Valuation & Earnings This table compares Aadi Bioscience and Arvinas’ […]